1
Uyl - de Groot, Carin, Rooijen, Ellen, Punt, CJA, Pescott, CP
Veröffentlicht in: Uyl - de Groot , C , Rooijen , E , Punt , CJA & Pescott , CP 2018 , ' Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands ' , Health Economics Review , vol. 8 , no. 1 , pp. 13 . https://doi.org/10.1186/s13561-018-0197-3;
2018
Veröffentlicht in: Uyl - de Groot , C , Rooijen , E , Punt , CJA & Pescott , CP 2018 , ' Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands ' , Health Economics Review , vol. 8 , no. 1 , pp. 13 . https://doi.org/10.1186/s13561-018-0197-3;
2018
2
3
de Groot, Saskia, Sleijfer, Stefan, Redekop, Ken, Oosterwijk, E, Haanen, JB, Kiemeney, LALM, Uyl - de Groot, Carin
Veröffentlicht in: de Groot , S , Sleijfer , S , Redekop , K , Oosterwijk , E , Haanen , JB , Kiemeney , LALM & Uyl - de Groot , C 2016 , ' Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry ' , BMC Cancer , vol. 16 , pp. 364 . https://doi.org/10.1186/s12885-016-2395-x;
2016
Veröffentlicht in: de Groot , S , Sleijfer , S , Redekop , K , Oosterwijk , E , Haanen , JB , Kiemeney , LALM & Uyl - de Groot , C 2016 , ' Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry ' , BMC Cancer , vol. 16 , pp. 364 . https://doi.org/10.1186/s12885-016-2395-x;
2016
4
Franken, Margreet, Kanters, Tim, Coenen, JL, De Jong, P, Koene, HR, Lugtenburg, Elly, Jager, Agnes, Uyl - de Groot, Carin
Veröffentlicht in: Franken , M , Kanters , T , Coenen , JL , De Jong , P , Koene , HR , Lugtenburg , E , Jager , A & Uyl - de Groot , C 2018 , ' Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 8 , pp. 791-801 . https://doi.org/10.1097/CAD.0000000000000648;
2018
Veröffentlicht in: Franken , M , Kanters , T , Coenen , JL , De Jong , P , Koene , HR , Lugtenburg , E , Jager , A & Uyl - de Groot , C 2018 , ' Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 8 , pp. 791-801 . https://doi.org/10.1097/CAD.0000000000000648;
2018
5
Blommestein, Hedwig, de Groot, Saskia, Aarts, MJ, Vemer, P (Pepijn), de Vries, R, Abeelen, AFM, Posthuma, EFM, Uyl - de Groot, Carin
Veröffentlicht in: Blommestein , H , de Groot , S , Aarts , MJ , Vemer , P , de Vries , R , Abeelen , AFM , Posthuma , EFM & Uyl - de Groot , C 2016 , ' Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands ' , Leukemia Research , vol. 50 , pp. 37-45 . https://doi.org/10.1016/j.leukres.2016.09.005;
2016
Veröffentlicht in: Blommestein , H , de Groot , S , Aarts , MJ , Vemer , P , de Vries , R , Abeelen , AFM , Posthuma , EFM & Uyl - de Groot , C 2016 , ' Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands ' , Leukemia Research , vol. 50 , pp. 37-45 . https://doi.org/10.1016/j.leukres.2016.09.005;
2016
6
Verelst, Silvia, Blommestein, Hedwig, de Groot, Saskia, Gonzalez-McQuire, S, DeCosta, L, de Raad, JB, Uyl - de Groot, Carin, Sonneveld, Pieter
Veröffentlicht in: Verelst , S , Blommestein , H , de Groot , S , Gonzalez-McQuire , S , DeCosta , L , de Raad , JB , Uyl - de Groot , C & Sonneveld , P 2018 , ' Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS) ' , HemaSphere , vol. 2 , no. 4 . https://doi.org/10.1097/HS9.0000000000000045;
2018
Veröffentlicht in: Verelst , S , Blommestein , H , de Groot , S , Gonzalez-McQuire , S , DeCosta , L , de Raad , JB , Uyl - de Groot , C & Sonneveld , P 2018 , ' Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS) ' , HemaSphere , vol. 2 , no. 4 . https://doi.org/10.1097/HS9.0000000000000045;
2018
7
Linden, Naomi, Buter, J, Pescott, CP, Lalisang, RI, de Boer, JP, de Graeff, A, van Herpen, CML, Baatenburg de Jong, R.J., Uyl - de Groot, Carin
Veröffentlicht in: Linden , N , Buter , J , Pescott , CP , Lalisang , RI , de Boer , JP , de Graeff , A , van Herpen , CML , Baatenburg de Jong , R J & Uyl - de Groot , C 2015 , ' Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands ' , European Archives of Oto-Rhino-Laryngology , vol. 273 , no. 2 , pp. 455-464 . https://doi.org/10.1007/s00405-015-3495-y;
2015
Veröffentlicht in: Linden , N , Buter , J , Pescott , CP , Lalisang , RI , de Boer , JP , de Graeff , A , van Herpen , CML , Baatenburg de Jong , R J & Uyl - de Groot , C 2015 , ' Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands ' , European Archives of Oto-Rhino-Laryngology , vol. 273 , no. 2 , pp. 455-464 . https://doi.org/10.1007/s00405-015-3495-y;
2015
8
Holtzer - Goor, KM (Kim Marleine), Schaafsma, MR, Joosten, P, Posthuma, EF, Wittebol, S, Huijgens, PC, Mattijssen, EJ, Vreugdenhil, G, Peters, WG, Erjavec, Z, Wijermans, PW, Daenen, SM, van der Hem, KG, van Oers, MH, Uyl - de Groot, Carin
Veröffentlicht in: Holtzer - Goor , KM , Schaafsma , MR , Joosten , P , Posthuma , EF , Wittebol , S , Huijgens , PC , Mattijssen , EJ , Vreugdenhil , G , Peters , WG , Erjavec , Z , Wijermans , PW , Daenen , SM , van der Hem , KG , van Oers , MH & Uyl - de Groot , C 2015 , ' Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study ' , Quality of Life Research , vol. 24 , no. 12 , pp. 2895-2906 . https://doi.org/10.1007/s11136-015-1039-y;
2015
Veröffentlicht in: Holtzer - Goor , KM , Schaafsma , MR , Joosten , P , Posthuma , EF , Wittebol , S , Huijgens , PC , Mattijssen , EJ , Vreugdenhil , G , Peters , WG , Erjavec , Z , Wijermans , PW , Daenen , SM , van der Hem , KG , van Oers , MH & Uyl - de Groot , C 2015 , ' Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study ' , Quality of Life Research , vol. 24 , no. 12 , pp. 2895-2906 . https://doi.org/10.1007/s11136-015-1039-y;
2015
9
Jochems, A, Leeneman, Brenda, Franken, Margreet, Schouwenburg, MG, Aarts, MJB, Akkooi, Alexander, van den Berkmortel, F, Van den Eertwegh, AJM, Groenewegen, G, de Groot, JWB, Haanen, JBAG, Hospers, GAP, Kapiteijn, E, Koornstra, RH, Kruit, Wim, Louwman, MW, Piersma, D, van Rijn, RS, ten Tije, AJ, Vreugdenhil, G, Wouters, MWJM, Uyl - de Groot, Carin, van der Hoeven, JJM
Veröffentlicht in: Jochems , A , Leeneman , B , Franken , M , Schouwenburg , MG , Aarts , MJB , Akkooi , A , van den Berkmortel , F , Van den Eertwegh , AJM , Groenewegen , G , de Groot , JWB , Haanen , JBAG , Hospers , GAP , Kapiteijn , E , Koornstra , RH , Kruit , W , Louwman , MW , Piersma , D , van Rijn , RS , ten Tije , AJ , Vreugdenhil , G , Wouters , MWJM , Uyl - de Groot , C & van der Hoeven , JJM 2018 , ' Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 6 , pp. 572-578 . https://doi.org/10.1097/CAD.0000000000000629;
2018
Veröffentlicht in: Jochems , A , Leeneman , B , Franken , M , Schouwenburg , MG , Aarts , MJB , Akkooi , A , van den Berkmortel , F , Van den Eertwegh , AJM , Groenewegen , G , de Groot , JWB , Haanen , JBAG , Hospers , GAP , Kapiteijn , E , Koornstra , RH , Kruit , W , Louwman , MW , Piersma , D , van Rijn , RS , ten Tije , AJ , Vreugdenhil , G , Wouters , MWJM , Uyl - de Groot , C & van der Hoeven , JJM 2018 , ' Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 6 , pp. 572-578 . https://doi.org/10.1097/CAD.0000000000000629;
2018
10
Franken, Margreet, Leeneman, Brenda, Jochems, A, Schouwenburg, MG, Aarts, MJB, Akkooi, ACJ, van den Berkmortel, F, Van den Eertwegh, AJM, de Groot, JWB, van der Hoeven, JJM, Hospers, GAP, Kapiteijn, E, Koornstra, RH, Kruit, Wim, Louwman, MW, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, ten Tije, AJ, Vreugdenhil, G, Wouters, MWJM, Zeijl, M, Haanen, JBAG, Uyl - de Groot, Carin
Veröffentlicht in: Franken , M , Leeneman , B , Jochems , A , Schouwenburg , MG , Aarts , MJB , Akkooi , ACJ , van den Berkmortel , F , Van den Eertwegh , AJM , de Groot , JWB , van der Hoeven , JJM , Hospers , GAP , Kapiteijn , E , Koornstra , RH , Kruit , W , Louwman , MW , Piersma , D , van Rijn , RS , Suijkerbuijk , KPM , ten Tije , AJ , Vreugdenhil , G , Wouters , MWJM , Zeijl , M , Haanen , JBAG & Uyl - de Groot , C 2018 , ' Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 6 , pp. 579-588 . https://doi.org/10.1097/CAD.0000000000000628;
2018
Veröffentlicht in: Franken , M , Leeneman , B , Jochems , A , Schouwenburg , MG , Aarts , MJB , Akkooi , ACJ , van den Berkmortel , F , Van den Eertwegh , AJM , de Groot , JWB , van der Hoeven , JJM , Hospers , GAP , Kapiteijn , E , Koornstra , RH , Kruit , W , Louwman , MW , Piersma , D , van Rijn , RS , Suijkerbuijk , KPM , ten Tije , AJ , Vreugdenhil , G , Wouters , MWJM , Zeijl , M , Haanen , JBAG & Uyl - de Groot , C 2018 , ' Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 6 , pp. 579-588 . https://doi.org/10.1097/CAD.0000000000000628;
2018